Catalyst (CPRX) Down 16.2% Since Last Earnings Report: Can It Rebound?
Nasdaq A month has gone by since the last earnings report for Catalyst Pharmaceutical (CPRX). Shares have lost about 16.2% in that time frame, underperforming the S&P 500.
Will the recent negative trend continue leading up to its next earnings release, or is Catalyst due for a breakout? Before we dive into how investors and analysts have reacted as of late, let's take a quick look at its most recent earnings report in order to get a better handle on the important drivers.
Catalyst Q1 Earnings Lag, Sales Boost Revenues
Catalyst Pharmaceuticals, Inc.reported earnings of 26 cents per share for the first quarter of 2023, missing the Zacks Consensus Estimate of 30 cents. However, earnings were higher than our estimate of 24 cents. The company reported earnings of 12 cents in the year-ago quarter.
Adjusted earnings (adjusted for stock-based compensation, depreciation, amortization and tax provision) came in at 41 cents per share in the reported quarter compared with 18 cents a year ago. Adjusted earnings also beat our estimate of 34 cents per share.
